Rhumbline Advisers Harmony Biosciences Holdings, Inc. Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 119,201 shares of HRMY stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,201
Previous 109,073 9.29%
Holding current value
$3.17 Million
Previous $3.62 Million 4.03%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$27.94 - $35.91 $282,976 - $363,696
10,128 Added 9.29%
119,201 $3.77 Million
Q1 2025

Apr 08, 2025
BUY
$32.18 - $40.46 $15,607 - $19,623
485 Added 0.45%
109,073 $3.62 Million
Q4 2024

May 29, 2025
SELL
$31.86 - $41.49 $15,452 - $20,122
-485 Reduced 0.44%
108,588 $3.74 Million
Q4 2024

Jan 30, 2025
BUY
$31.86 - $41.49 $526,868 - $686,120
16,537 Added 17.97%
108,588 $3.74 Million
Q3 2024

Nov 12, 2024
SELL
$30.0 - $39.95 $259,290 - $345,287
-8,643 Reduced 8.58%
92,051 $3.68 Million
Q2 2024

Aug 01, 2024
SELL
$28.81 - $33.01 $98,559 - $112,927
-3,421 Reduced 3.29%
100,694 $3.04 Million
Q1 2024

May 09, 2024
BUY
$29.93 - $35.06 $106,850 - $125,164
3,570 Added 3.55%
104,115 $3.5 Million
Q4 2023

Feb 08, 2024
SELL
$19.2 - $33.78 $35,251 - $62,020
-1,836 Reduced 1.79%
100,545 $3.25 Million
Q3 2023

Nov 09, 2023
BUY
$31.89 - $39.03 $239,653 - $293,310
7,515 Added 7.92%
102,381 $3.36 Million
Q2 2023

Aug 08, 2023
BUY
$30.5 - $37.4 $317,932 - $389,857
10,424 Added 12.34%
94,866 $3.34 Million
Q1 2023

May 11, 2023
BUY
$30.8 - $53.92 $140,355 - $245,713
4,557 Added 5.7%
84,442 $2.76 Million
Q4 2022

Feb 14, 2023
BUY
$45.4 - $60.91 $18,750 - $25,155
413 Added 0.52%
79,885 $4.4 Million
Q3 2022

Nov 10, 2022
BUY
$42.06 - $55.45 $549,934 - $725,008
13,075 Added 19.69%
79,472 $3.52 Million
Q2 2022

Aug 11, 2022
BUY
$33.54 - $52.15 $238,335 - $370,577
7,106 Added 11.98%
66,397 $3.24 Million
Q1 2022

May 12, 2022
BUY
$33.14 - $51.13 $188,964 - $291,543
5,702 Added 10.64%
59,291 $2.89 Million
Q4 2021

Feb 10, 2022
BUY
$34.09 - $43.91 $1.14 Million - $1.47 Million
33,492 Added 166.65%
53,589 $2.29 Million
Q3 2021

Nov 12, 2021
BUY
$25.68 - $38.61 $28,170 - $42,355
1,097 Added 5.77%
20,097 $770,000
Q2 2021

Aug 05, 2021
BUY
$25.96 - $33.44 $493,240 - $635,360
19,000 New
19,000 $536,000

Others Institutions Holding HRMY

# of Institutions
290
Shares Held
46.3M
Call Options Held
316K
Put Options Held
69.9K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.57B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email